[Blog] What to expect from the onboarding process of the UAE traceability system?
The latest technical guidelines for onboarding the UAE traceability system, Tatmeen, were announced.
We are following the development of the UAE traceability system that the previous year officially announced its establishment. The Tatmeen platform was created in partnership between MOHAP, Dubai Health Authority (DHA) and EVOTEQ, enabling the traceability of pharma products across the supply chain. In May, the MoHAP legislation on the Serialization and Track and Trace (T&T) requirements has a new version of the technical guide.
The document defines in detail the whole process of onboarding for partners that will connect electronically with the UAE traceability system. The guide applies to 3PLs, Batch releasers, CMOs, Dispensers, Distributors, Domestic/ Foreign Manufacturers, Licensing agents, MAHs and MAH Scientific Offices.
The technical onboarding follows the process:
- Request Technical User
- Tatmeen Staging Onboarding
- Tatmeen Staging Qualification
- Tatmeen Production Onboarding
*Technical onboarding depends on the organization‘s nature represented by the business partner. Many organizations will choose to share electronic records with the Tatmeen system to meet the UAE MoHAP legislation and must follow the process.
*As referred to, the Tatmeen environment consists of a test environment (STAGING) and a single highly available production environment (PRODUCTION). The STAGING environment is intended for onboarding partners to test their test systems’ connection to the Tatmeen API. The partner must have a successful connection to connect to the PRODUCTION environment. Regarding the Production, its primary purpose is for live transactions and messaging.
Tatmeen is the Information Technology (IT) regulatory system that will support the UAE T&T legislation for the pharmaceutical industry. All products placed on the UAE market must display a serialized unique identifier on the secondary product packaging. Also, aggregated packaging (aggregated homogenous products or logistics units) must display a serialized unique identifier. The appropriate serialized identifiers must be used to record the operational and transactional movements of the products throughout the supply chain and during dispensing to the patient/consumer.